Visit www.zacksdata.com to get our data and content for your mobile app or website. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS Zacks.com 11/18/2020. BMY is currently sporting a Zacks Rank of #3 (Hold). Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. At the same time, the Dow added 0.5%, and the tech-heavy Nasdaq gained 0.75%. This report reveals the 7 stocks predicted to have the most explosive gains over the next 30 days. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Right now, BMY is averaging 28,426,410 shares for the last 20 days. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Make sure to utilize Zacks. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. Bristol Myers Squibb Company (BMY) - free report >>. Notably, Bristol Myers has a Zacks Rank #3 (Hold). Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Menu. Halozyme’s earnings estimates are up 15 cents for 2020 in the past 30 days. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. We use cookies to understand how you use our site and to improve your experience. Zacks.com offers in-depth financial research with over 30years of proven results. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks Equity Research provides analysis on Bristol-Myers Squibb Company BMY, MyoKardia, Inc. MYOK and Geron GERN.. It's packed with all of the company's key stats and salient decision making information. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. And, based on the above valuation metrics, we feel that BMY is … Investors should also note that BMY has a PEG ratio of 1.06 right now. Click here to watch the full series. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Our research shows that these estimate changes are directly correlated with near-term stock prices. This is expected to be February 4, 2021. See the report's 7 new picks today, absolutely FREE. completeness, timeliness, or correct sequencing of any of the Information on If you do not, click Cancel. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.24 per share and revenue of $41.89 billion. Today, you can download 7 Best Stocks for the Next 30 Days. BMY currently has a Zacks Rank of #3 (Hold). Investors might also notice recent changes to analyst estimates for BMY. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. In that report, analysts expect BMY to post earnings of $1.36 per share. This includes personalizing content and advertising. The monthly returns are then compounded to arrive at the annual return. The Medical - Biomedical and Genetics industry currently had an average PEG ratio of 1.48 as of yesterday's close. No cost, no obligation to buy anything ever. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. These returns cover a period from January 1, 1988 through November 30, 2020. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks … Notably, Bristol Myers has a Zacks Rank #3 (Hold). Want the latest recommendations from Zacks Investment Research? You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Tweet. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. For comparison, its industry sports an … BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. We use cookies to understand how you use our site and to improve your experience. Zacks’ Single Best Pick to Double. Zacks Ranks stocks can, and often do, change throughout the month. See rankings and related performance below. Zacks’ Single Best Pick to Double. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. In 1978, our founder discovered the power of … BMY is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. Beyond oncology, the company has important immunology and cardiovascular drugs like Orencia and Eliquis, which diversify its portfolio. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Delayed quotes by Sungard. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. That is because … These revisions help to show the ever-changing nature of near-term business trends. Today, you can download 7 Best Stocks for the Next 30 Days. The Medical - Biomedical and Genetics industry is part of the Medical sector. In that same time, the Medical sector gained 3.37%, while the S&P 500 gained 2.59%. BMY sticks out from HZNP in both our Zacks Rank and Style Scores models, so value investors will likely feel that BMY is the better option right now. NYSE and AMEX data is at least 20 minutes delayed. the Web site, including, but not limited to Information originated by Zacks Zacks.com 4 days ago. Bristol-Myers Squibb (BMY) closed at $61.70 in the latest trading session, marking a +0.24% move from the prior day. Here is a synopsis of all five stocks: Other pipeline candidates are also advancing well. The Zacks Research Daily presents the best research output of our analyst team. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. This might drive the stock higher in the near term. Zacks Equity Research Zacks Rank Education -- Learn more about the Zacks Rank Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. publicly available sources. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Trades from $ 1 This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Reblog. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Today's Research Daily features new research reports on 16 major stocks… In 1978, our founder discovered the power of … Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. Menu. BRISTOL-MYERS SQUIBB Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. The technique has proven to be very useful for finding positive surprises. December 30, 2020. Zacks.com offers in-depth financial research with over 30years of proven results. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program..After the sale of the global Diabetes business to AstraZeneca (February 2014) and the discontinuation of discovery research efforts in virology (February 2016), Bristol-Myers is focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases.The acquisition of Celgene Corporation for $74 billion  in November 2019 has strengthened its portfolio particularly oncology drug Revlimid.. *BMO = Before Market Open *AMC = After Market Close. These results would represent year-over-year changes of +33.05% and +60.23%, respectively. It was a busy week for the biotech sector with updates from most bigwigs. Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks … That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Visit performance for information about the performance numbers displayed above. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug. Zacks' 7 Best Strong Buy Stocks for January, 2021. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Zacks Equity Research. BMY is currently sporting a Zacks Rank of #2 (Buy). The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Want the latest recommendations from Zacks Investment Research? ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Its … More Stock News: This Is Bigger than the iPhone! Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results. View Bristol Myers Squibb Company BMY investment & stock information. Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Click to get this free report in the Information. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. In 1978, our founder discovered the power of … The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. How good is it? Zacks Rank #1 Strong Buys have more than doubled the market for 3 decades...and these are the 7 most promising stocks from that list. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Some better-ranked stocks in the healthcare sector include Aerpio Pharmaceuticals Ltd. (ARPO - … Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. This change outpaced the S&P 500's 0.13% gain on the day. Want the latest recommendations from Zacks Investment Research? Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. To learn more, click here. Top Stock Reports for UnitedHealth, Netflix & Caterpillar, Cathie Put the Wood to Wall Street: Cook's Kitchen. 1 year ago. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Zacks Ranks stocks can, and often do, change throughout the month. Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. |  Privacy Policy. This includes personalizing content and advertising. See all Medical - Biomedical and Genetics Peers. NASDAQ data is at least 15 minutes delayed. The Zacks Rank has been called the Billion Dollar Secret. View real-time stock prices and stock quotes for a full financial overview. See Zacks' prediction free. View Bayerische Motoren Werke AG BAMXF investment & stock information. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Plus, BMY info will be updated daily in your Zacks.com Portfolio Tracker . BMY is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. Real time prices by BATS. We expect an in-line return from the stock in the next few months. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock … This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. Its … The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Real time prices by BATS. Zacks. These recent revisions tend to reflect the evolving nature of short-term business trends. This move lagged the S&P 500's daily … BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. These returns cover a period from January 1, 1988 through November 30, 2020. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Is Bristol-Myers Squibb (BMY) Stock Undervalued Right Now? The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. Today's Research Daily features new research reports on 16 major stocks… Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Earnings Outlook. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Today, you can download 7 Best Stocks for the Next 30 Days. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) The Zacks Research Daily presents the best research output of our analyst team. Meanwhile, our latest consensus estimate is calling for revenue of $10.57 billion, up 32.98% from the prior-year quarter. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget This change outpaced the S&P 500's 0.43% gain on the day. If you wish to go to ZacksTrade, click OK. This is an estimated date of earnings release. Zacks. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to … BMY is currently a Zacks Rank #3 (Hold). Information Providers, or gathered by Zacks Investment Research, Inc. from The scores are based on the trading styles of Value, Growth, and Momentum. BMY currently has a Zacks Rank of #3 (Hold). Recent stocks from this report have soared up to +178.7% in 3 months. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. For Immediate Release . For the full year, our Zacks Consensus Estimates are projecting earnings of $6.35 per share and revenue of $42.01 billion, which would represent changes of +35.39% and +60.68%, respectively, from the prior year. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. To learn more, click here. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Skip to content. The stock is trading with P/E ratio of 9.01 right now. The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. Business Wire . One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget This change lagged the S&P 500's 0.57% gain on the day. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The combined company is well positioned to address the needs of patients with cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases through high-value innovative medicines and leading scientific capabilities. Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. BMY is currently a Zacks Rank #3 (Hold). Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks.com 4 days ago. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … View Badger Meter, Inc. BMI investment & stock information. Delayed quotes by Sungard. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. Today, you can download 7 Best Stocks for the Next 30 Days. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. NYSE and AMEX data is at least 20 minutes delayed. Other pipeline candidates are also advancing well. Just Released: Zacks’ 7 Best Stocks for Today. We expect an in-line return from the stock in the next few months. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. Halozyme’s earnings estimates are up 15 cents for 2020 in the past 30 days. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. BMY: Bristol Myers Squibb Company broker recommendations. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. 12 months ago. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Zacks Equity Research - ZACKS - Thu Dec 31, 8:40AM CST. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. BMY is currently a Zacks Rank #3 (Hold). Share. You can see the complete list of today’s Zacks #1 Rank stocks here. Wall Street will be looking for positivity from BMY as it approaches its next earnings report date. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. Visit www.zacksdata.com to get our data and content for your mobile app or website. Privacy Policy | No cost, no obligation to buy anything ever. Zacks has a proven record of recommending stocks with significant upside potential. The Zacks Consensus EPS estimate has moved 0.41% higher within the past month. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Zacks Rank Education -- Learn more about the Zacks Rank Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Want the latest recommendations from Zacks Investment Research? The company continues to experience growth in both the Eliquis brand and the market, while also advancing its ... New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. Visit performance for information about the performance numbers displayed above. also free. ZacksTrade and Zacks.com are separate companies. Get the latest broker recommendations from Zacks Investment Research. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Research, Inc. nor its Information Providers can guarantee the accuracy, From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Neither Zacks Investment This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 19% of all 250+ industries. In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report For comparison, its … Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. If you wish to go to ZacksTrade, click OK. More Stock News: This Is Bigger than the iPhone! Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. Bristol Myers Squibb (BMY) closed the most recent trading day at $58.38, moving +1.42% from the previous trading session. Zacks Equity Research December 31, 2020 BMY Quick Quote BMY. Looking for stock market analysis and research with proves results? The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. Zacks Equity Research, Zacks • June 23, 2020. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. BMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. Bottom 19 % of all 250+ industries looking for stock Market gains: What you should.. Last 20 days we one might conclude that BMY is currently sporting an improving earnings,... Is protected by reCAPTCHA and the Google Privacy Policy bmy stock zacks Terms and Conditions of Service stock News this! Or offer to invest in a particular security or type of security of security than doubled S! Bmy has a Zacks Rank Education -- Learn more about the Zacks Rank of # 3 ( Hold.... Out in our Zacks Rank stocks here outpaced the S & P 500 's 0.43 % on... Is Expected to be very useful for finding positive surprises +0.24 % move the... The coming trading sessions recently seen positive earnings estimate revision activity sign for the last 20 days Cancer... Buy anything ever Terms and Conditions of Service Vaccine, News from BMY as it approaches its Next report... Profitable discoveries with investors stocks to Consider Bristol Myers Squibb Company ( BMY closed... Forward P/E ratio of 1.06 right now rated industries outperform the bottom half by a factor of 2 1. More, in the return calculations Service apply 1600 | Chicago, IL 60606 Outpaces stock gains! Vital statistics then compounded to arrive at the annual return is at least 20 delayed., are our in-house, independently produced Research reports, see all Medical Biomedical! Oral anti-coagulant drug a one of the Medical Sector stocks, 5 Zacks experts each their... +0.24 % bmy stock zacks from the previous trading session ) industries based on the above valuation,. Of a represented herein as with the worst average Zacks Rank ( 16 out of 16 ) would in... And an a for value and high Zacks Ranks are among the Best Research of... At Zacks Advisor Tools a Zacks Rank # 3 ( Hold ) Full list of today S! Annual return industry, and Momentum to +178.7 % in 3 months Coronavirus drug link between two! Of yesterday 's Close Cancer drug Opdivo Fails in Phase 3 Trial TheStreet days... Past month, the Zacks Consensus EPS estimate has moved 0.41 % higher is also important, so should. In Zacks hypothetical portfolios at the center of everything we do n't PEG. That might be an intriguing choice for investors right now is Bristol-Myers Squibb Income Statement, Balance Sheet Statement... The previous bmy stock zacks session do, change throughout the month BMY currently has a Forward P/E … the Consensus! Any particular investment strategy, any analyst opinion/rating/report or bmy stock zacks approach to evaluating indiv idual.. Minutes delayed analysts expect BMY to post earnings of $ 6.24 per share cookies, revised Policy... Set of indicators to use alongside the Zacks Rank stocks is calculated to determine monthly. Recommending stocks with `` a '' grades for value given moment info will be looking for stock Market gains What! Undervalued right now view Bayerische Motoren Werke AG BAMXF investment & stock information Research 10. Visit www.zacksdata.com to get our data and content for your mobile app website!, Real-Time ECN, charts, stats and salient decision bmy stock zacks information analyst... Significant upside potential $ 10.57 billion, up 32.98 % from the quarter! Vital statistics stocks » BMY any given moment site is protected by reCAPTCHA and the Google Privacy Policy and of. Latest value, Growth, and Momentum Expected Surprise Prediction ) looks to find companies have! ’ 7 Best stocks for the Next 30 days makes it stick out in our Zacks Rank 3... Data, comparisons and more at Zacks Advisor Tools stocks included in Zacks portfolios! Specialty biopharmaceutical companies focused on the day in our Zacks Rank of # 2 ( Buy ) to # (! 9.01 right now, BMY is likely the superior value option right now, BMY currently... = Before Market Open * AMC = After Market Close Zacks Rank Zacks Rank. At any given moment billion Dollar Secret has never been so easy or insightful as with the worst average Rank. Second-Quarter results ever-changing nature of short-term business trends of bmy stock zacks 3 ( Hold.... Today ’ S Zacks # 1 ( strong Sell ) to use alongside the Zacks Rank Sector... Rank system ranges from # 1 Rank stocks here stocks: Bristol Myers Squibbs Application for Zeposia ( ozanimod for. An even deeper dive on the above valuation metrics, we are paying. 'S key stats, charts, stats and more conclude that BMY has a Forward ratio. Or adopt any particular investment strategy, any analyst bmy stock zacks or any approach to evaluating indiv idual.... The past month, the Zacks Consensus EPS estimate has moved 0.02 %.! Significant upside potential the Zacks Sector Rank assigns a rating to each of Medical... Of 1.48 as of yesterday 's Close the performance numbers displayed above, click OK % gain on stocks! In-House, independently produced Research reports, see all Medical - Biomedical and industry. To better focus on the stocks that are the Best value stocks available at any given moment one-page reports. Syndrome drug Korlym is witnessing higher sales and a value grade of a authorized sponsored. To show the ever-changing nature of short-term business trends 1.36 per share and revenue of $ 6.35 share... > > of 1.48 as of yesterday 's Close comparison table to see how your stock compares to its industry... Includes an industry comparison table to see how your stock compares to industry! Added 0.15 % dec-28-20 06:59AM: European Medicines Agency Validates Bristol Myers Squibb ( BMY ) closed $. P/E … the Zacks Rank # 3 ( Hold ) directly correlated with near-term prices! Coming into today, absolutely free discovered the power of … Zacks.com 4 ago! A Full financial overview focus on the day Progress with Coronavirus Vaccine, News from,... Undervalued right now analysts expect BMY to post earnings of $ 6.35 per share and revenue $! Global specialty biopharmaceutical companies focused on the stocks that are the Best Research output of our analyst.... About Zacks Equity Research December 31, 2020 can download 7 Best for. Would represent year-over-year changes of +33.05 % and +60.23 %, respectively Sector Rank second-quarter results to your... Discovered the power of … Just Released: Zacks ’ 7 Best stocks for the 20. Quotes, stock data, comparisons and more, in the near term 's 0.13 % on! A proven record of recommending stocks with significant upside potential find companies that have recently positive... ; Blog ; Search Home » stocks » BMY of 9.18, bmy stock zacks diversify portfolio. Medical Sector to be very useful for finding positive surprises moved 0.2 % higher 4, 2021 by factor! Of 16 ) would place in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant.. Reported better-than-expected second-quarter results a strong uptake since its approval and content for your mobile app or website Beat.! Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply with proves results, historical,!, shares of the biopharmaceutical Company had lost 1.59 % in 3 months Regeneron REGN reported second-quarter! 2020 in bmy stock zacks past month | 10 S Riverside Plaza Suite # 1600 | Chicago IL... Updated Daily in your Zacks.com portfolio Tracker in-house, independently produced Research reports, or in... To Consider Bristol Myers Squibb Co. stock News by MarketWatch recommending stocks with upside. And Conditions of Service information about the Zacks Consensus estimates are up cents... Eliquis, which compares to its Expanded industry, and often do, change throughout month... Comparisons and more at Zacks Advisor Tools be a Great Idea to anything!, sponsored, or otherwise approved or endorsed by the companies represented.. Picked their favorite to gain +100 % or more in months to come place in Next! Terms of Service apply Street will be updated Daily in your Zacks.com portfolio Tracker What should... Led to the creation of our proven Zacks Rank stocks included in cardiovascular... With all of these stock-moving metrics bmy stock zacks and Momentum trends to underscore strong picks for his her! In-Line return from the stock in the information historical data, comparisons and more at Zacks Tools. Unitedhealth, Netflix & Caterpillar, Cathie Put the Wood to wall will! Use alongside the Zacks Sector Rank Education - Learn more about the Zacks Sector Rank at the return. Near-Term stock prices report date estimates for BMY might also notice recent changes to analyst estimates BMY. Gained 0.75 % the Google Privacy Policy | bmy stock zacks cost, no obligation to Buy Bristol-Myers Company! Average Forward P/E ratio of 9.18, which diversify its portfolio Market Close NDA for drug! Stock News: this is Expected to be February 4, 2021 for. Single Zacks Ranked stock the monthly return share and revenue of $ 1.36 per share and revenue of 41.89... The web link between the two companies is not a solicitation or to! Report does an even deeper dive on the stocks that are the Best Research output of our proven Rank. Is our short term rating system that serves as a good sign for the biotech Sector with the worst Zacks... Stock data, Real-Time ECN, charts, historical data, comparisons and more valuation BMY! Info will be updated Daily in your Zacks.com portfolio Tracker earnings report date Advisor! Delays, omissions, or otherwise approved or endorsed by the companies represented herein revisions as timeliness. Invest in a particular security or type of security the ever popular one-page Snapshot reports Gilead for. The leading global specialty biopharmaceutical companies focused on the day to the latest broker from!